Elevated expression of integrin αv and β5 subunit in laryngeal squamous-cell carcinoma associated with lymphatic metastasis and angiogenesis

Pathology Research and Practice

Volumn 209, Issue 2, 2013, Pages 105-109

  Li, Feng ^a   Liu, Ying ^a   Kan, Xuan ^a   Li, Yong ^a   Liu, Ming ^a   Lu, Jian Guang ^a  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

v integrin; 5 integrin; Angiogenesis; Laryngeal neoplasm; Metastasis

Indexed keywords

ALPHA5 INTEGRIN; BETA INTEGRIN; BETA1 INTEGRIN; BETA3 INTEGRIN; BETA5 INTEGRIN; BETA6 INTEGRIN; BETA8 INTEGRIN; ENDOGLIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNGEAL SQUAMOUS CELL CARCINOMA; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; RECEPTORS, VITRONECTIN; TUMOR MARKERS, BIOLOGICAL;

EID: 84873731535     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2012.11.001     Document Type: Article

References (34)

1. Ruoslahti E., Integrins J. Clin. Invest. 1991, 87:1-5.
2. Kumar C.C. Signaling by integrin receptors. Oncogene 1998, 17:1365-1373.
3. Sanders R.J., Mainiero F., Giancotti F.G. The role of integrins in tumorigenesis and metastasis. Cancer Invest. 1998, 16:329-344.
4. Varner J.A., Cheresh D.A. Integrins and cancer. Curr. Opin. Cell Biol. 1996, 8(5):724-730.
5. Pasqualini R., Koivunen E., Ruoslahti E. Alpha v integrins as receptors for tumor targeting by circulating ligands. Nat. Biotechnol. 1997, 15:542-546.
6. Felding-Habermann B., Mueller B.M., Romerdahl C.A., Cheresh D.A. Involvement of integrin αv gene expression in human melanoma tumorigenicity. J. Clin. Invest. 1992, 89:2018-2022.
7. Eliceiri B.P., Cheresh D.A. The role of alpha v integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J. Clin. Invest. 1999, 103:1227-1230.
8. Bhaskar V., Zhang D., Fox M., et al. A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo. J. Transl. Med. 2007, 5:61.
9. Weidner N., Semple J.P., Welch W.R., Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 1991, 324:1-8.
10. Duff S.E., L I C., Garland J.M., Kumar S. CD105 is important for angiogenesis: evidence and potential applications. FASEB J. 2003, 17:984-992.
11. Li C., Guo B., Wilson P.B., et al. Plasma levels of soluble CD105 correlate with metastasis in patientswith breast cancer. Int. J. Cancer 2000, 89:122-126.
12. Licitra L., Bernier J., Grandi C. Cancer of the larynx. Crit. Rev. Oncol. Hematol. 2003, 47:65-80.
13. Lu J.G., Li Y., Li L., Kan X. Overexpression of osteopontin and integrin αv in laryngeal and hypopharyngeal carcinomas associated with differentiation and metastasis. J. Cancer Res. Clin. Oncol. 2011, 137(11):1613-1618.
14. Lu J.G., Sun Y.N., Wang C., Jin de J., Liu M. Role of the alpha v-integrin subunit in cell proliferation, apoptosis and tumor metastasis of laryngeal and hypopharyngeal squamous cell carcinomas: a clinical and in vitro investigation. Eur. Arch. Otorhinolaryngol. 2009, 266:89-96.
15. Hynes R.O. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110:673-687.
16. Giancotti F.G., Ruoslahti E. Integrin signaling. Science 1999, 285:1028-1032.
17. Jones J., Watt F.M., Speight P.M. Changes in the expression of alpha v integrins in oral squamous cell carcinomas. J. Oral Pathol. Med. 1997, 26:63-68.
18. Sethi T., Rintoul R.C., Moore S.M., et al. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat. Med. 1999, 5:662-668.
19. Oshita F., Kameda Y., Hamanaka N., et al. High expression of integrin β1 and p53 is a greater poor prognostic factor than clinical stage in small-cell lung cancer. Am. J. Clin. Oncol. 2004, 27:215-219.
20. Bottger T.C., Maschek H., Lobo M., Gottwohl R.G., Brenner W., Junginger T. Prognostic value of immunohistochemical expression of β-1 integrin in pancreatic carcinoma. Oncology 1999, 56:308-313.
21. Brooks P.C., Strömblad S., Sanders L.C., et al. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 1996, 85:683-693.
22. Parise L.V., Lee J., Juliano R.L. New aspects of integrin signaling in cancer. Semin. Cancer Biol. 2000, 10:407-414.
23. Christine W.B., Michael W., Wolfgang W. Molecular determinants of glioma cell migration and invasion. J. Neurosurg. 2001, 94:978-984.
24. Kumar C.C., Malkowski M., Yin Z., et al. Inhibition of angiogenesis and tumor growth by SCH221153, a dual α(v)β3 and α(v)β5 integrin receptor antagonist. Cancer Res. 2001, 61:2232-2238.
25. Mitjans F., Meyer T., Fittschen C., et al. In vivo therapy of malignant melanoma by means of antagonists of αv integrins. Int. J. Cancer 2000, 87:716-723.
26. MacDonald T.J., Taga T., Shimada H., et al. Preferential susceptibility of brain tumors to the antiangiogenic effects of an α(v) integrin antagonist. Neurosurgery 2001, 48:151-157.
27. Hecht J.L., Dolinski B.M., Gardner H.A., Violette S.M., Weinreb P.H. Overexpression of the alphavbeta6 integrin in endometrial cancer. Appl. Immunohistochem. Mol. Morphol. 2008, 16(6):543-547.
28. Bates R.C., Bellovin D.I., Brown C., et al. Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J. Clin. Investig. 2005, 115:339-347.
29. Yang G.Y., Xu K.S., Pan Z.Q., et al. Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver. Cancer Sci. 2008, 99:879-887.
30. Zhang Z.Y., Xu K.S., Wang J.S., et al. Integrin alpha v beta 6 acts as a prognostic indicator in gastric carcinoma. Clin. Oncol. (R Coll. Radiol.) 2008, 20:61-66.
31. Sipos B., Hahn D., Carceller A., et al. Immunohistochemical screening for beta6-integrin subunit expression in adenocarcinomas using a novel monoclonal antibody reveals strong up-regulation in pancreatic ductal adenocarcinomas in vivo and in vitro. Histopathology 2004, 45:226-236.
32. Arihiro K., Kaneko M., Fujii S., Inai K., Yokosaki Y. Significance of alpha 9 beta 1 and alpha v beta 6 integrin expression in breast carcinoma. Breast Cancer 2000, 7:19-26.
33. Choi S.H., Cho K.J., Nam S.Y., Lee S.W., Kang J., Kim S.Y. Clinical significance of beta1 integrin expression as a prediction marker for radiotherapy in early glottic carcinoma. Laryngoscope 2006, 116(7):1228-1231.
34. Kawahara E., Ooi A., Nakanishi I. Integrin distribution in gastric carcinoma: association of beta 3 and beta 5 integrins with tumor invasiveness. Pathol. Int. 1995, 45(7):493-500.